2019 China's top 100 pharmaceutical industry list, a large number of Chinese medicine enterprises "swipe screen"

On August 6-8, 2020, the 13th China Pharmaceutical Industry Development Summit Forum, hosted by the National Federation of Industry and Commerce, was held in Nanchang, Jiangxi Province, at which the 2019 Top 100 List of China's Pharmaceutical Industry was released.
it is understood that the list has been held six consecutive times, has become China's pharmaceutical industry's annual brand event.
the top three, Yangzijiang Pharmaceuticals remains at the top of the list, followed by Correctional Pharmaceuticals and Colum Pharmaceuticals.
, it's also a revision of the pharmaceutical industry's fifth consecutive year of third place and regaining second place in the rankings.
addition, Shipharma Holdings, Jimin Trust, Yunnan White Pharmaceuticals, Fosun Pharma, Hengrui Pharmaceuticals, Renfu Pharmaceuticals, Qilu Pharmaceuticals ranked in the top 10.
In addition, one of the highlights of this list is that a large number of Chinese medicine enterprises have emerged on the list, in addition to the revision of the pharmaceutical industry, good doctors group, Treasure Island Pharmaceuticals, Jiuzhitang, Yunnan White Medicine, Sunflower Pharmaceuticals, Shenwei Pharmaceuticals, Pills pharmaceutical industry and a large number of enterprises involved in the Chinese medicine industry are listed.
this year, affected by the special period, Chinese medicine has been re-recognized by the industry, the industry is highly concerned, the relevant relevant relevant relevant relevant policies are also being introduced to promote the development of the Chinese medicine industry.
the strength of these listed Chinese medicine enterprises, but also conducive to promoting the development of the industry.
, Shenwei Pharmaceuticals to "lead the modern Chinese medicine, promote the health industry" as the mission, is to modern Chinese medicine as the main industry of large-scale integrated enterprise groups. For more than
years, has been committed to providing the people with safe, effective, stable and reliable high-quality drugs, and actively expand the upper, middle and lower reaches of the industrial chain, the main business covers modern Chinese medicine cultivation, research and development, production, sales, retail, e-commerce, formula particles, Chinese medicine diagnosis and treatment rehabilitation, biological preparations, health care products, functional food and so on.
At present, Shenwei Pharmaceuticals in the development of modern Chinese medicine injections, modern Chinese medicine softgels, modern Chinese medicine granules, Chinese medicine formula particles four characteristics of the four characteristics of the dosage form, but also continue to expand the elderly, children, antivirals, orthopaedic drugs and other high-speed growth of the market, has more than 100 million yuan of modern Chinese medicine varieties.
Pythalmic medicine industry is to pharmaceutical manufacturing, research and development as the main industry of the national technology innovation demonstration enterprises, its core varieties of Pythalm is the national level of Chinese medicine protection varieties, national intangible cultural heritage, with nearly 500 years of history, but also known as the national treasure medicine, the maritime Silk Road on the "Chinese symbol."
it is understood that the pharmaceutical industry will promote the integration of modern science and technology and traditional Chinese medicine through continuous innovation research, and effectively promote the high-quality integration and development of the Chinese medicine industry.
While inheriting traditional Chinese medicine theory, culture and medical technology, Jiuzhitang, guided by the health needs of the people in the new era, explores the layout of the same-source series of products, at the same time, integrates traditional medicine and precision medicine, conforms to the policy orientation of the state to vigorously develop Internet medical treatment, relies on "Internet and Chinese medicine", explores and promotes Internet hospital projects, and has been put into trial operation.
Chitang is also selected for many years in China's top 100 pharmaceutical industry.
it is understood that Jiuzhitang has now developed into a more than 30 molecular companies under its jurisdiction, with more than 400 chain stores, set production, sales, scientific research, health management in one of the modern large-scale pharmaceutical enterprises.
.